Exact Mass: 157.9804

Exact Mass Matches: 157.9804

Found 47 metabolites which its exact mass value is equals to given mass value 157.9804, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Mustard gas

1-chloro-2-[(2-chloroethyl)sulfanyl]ethane

C4H8Cl2S (157.9724)

D011042 - Poisons > D002619 - Chemical Warfare Agents > D009151 - Mustard Gas D009676 - Noxae > D011042 - Poisons > D002619 - Chemical Warfare Agents D003879 - Dermatologic Agents

1,2-Bis(chloromethoxy)ethane

Ethane,1,2-bis(chloromethoxy)-

C4H8Cl2O2 (157.9901)

5-chlorohydroxyquinone

5-Chloro-2-hydroxy-p-benzoquinone

C6H3ClO3 (157.9771)

2-Chloro-6-hydroxy-1,4-benzoquinone

C6H3ClO3 (157.9771)

Calcium acetate

Acetic acid, calcium salt (2:1)

C4H6CaO4 (157.9892)

It is used in foods as a firming agent, acidity regulator, sequestrant, stabiliser and thickener, and nutrient supplement (Ca source). It is used as an acidifier/preservative in bread, and in some gelling mixtures. Calcium acetate is a food additive, mainly in candy products.; Calclacite is a name for calcium acetate chloride pentahydrate, which is treated as mineral species but possess anthropogenic origin.; Patients with advanced renal insufficiency (creatinine clearance less than 30 ml/min) exhibit phosphate retention and some degree of hyperphosphatemia. The retention of phosphate plays a pivotal role in causing secondary hyperparathyroidism associated with osteodystrophy, and soft-tissue calcification. The mechanism by which phosphate retention leads to hyperparathyroidism is not clearly delineated. Therapeutic efforts directed toward the control of hyperphosphatemia include reduction in the dietary intake of phosphate, inhibition of absorption of phosphate in the intestine with phosphate binders, and removal of phosphate from the body by more efficient methods of dialysis. The rate of removal of phosphate by dietary manipulation or by dialysis is insufficient. Dialysis patients absorb 40\\% to 80\\% of dietary phosphorus. Therefore, the fraction of dietary phosphate absorbed from the diet needs to be reduced by using phosphate binders in most renal failure patients on maintenance dialysis. Calcium acetate when taken with meals combines with dietary phosphate to form insoluble calcium phosphate which is excreted in the feces. Maintenance of serum phosphorus below 6.0 mg/dl is generally considered as a clinically acceptable outcome of treatment with phosphate binders. Calcium acetate is highly soluble at neutral pH, making the calcium readily available for binding to phosphate in the proximal small intestine. It is used in foods as a firming agent, acidity regulator, sequestrant, stabiliser and thickener, and nutrient supplement (Ca source). It is used as an acidifier/preservative in bread, and in some gelling mixtures V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia D064449 - Sequestering Agents > D002614 - Chelating Agents

dichlorophenylborane

C6H5BCl2 (157.9861)

5-(Methylthio)thiophene-2-carboxaldehyde

C6H6OS2 (157.986)

tert-Butyldichlorophosphine